Anastasios Boutis

SERUM CYFRA 21–1 IN PATIENTS WITH INVASIVE BLADDER CANCER AND ITS RELEVANCE AS A TUMOR MARKER DURING CHEMOTHERAPY

C. Andreadis, Stavros Touloupidis, G. Galaktidou et al. · The Journal of Urology · 2005 · 41 citations

Medicine, Oncology, Urology +17

Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group

Elena Fountzilas, Sofia Lampaki, Georgia-Angeliki Koliou et al. · Cancer Immunology Immunotherapy · 2021 · 39 citations · Full text

Life Sciences, Immunology, Oncology +17

Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group

Elena Fountzilas, Georgia-Angeliki Koliou, Athanassios Vozikis et al. · ESMO Open · 2020 · 38 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17

Diabetes Mellitus Secondary to Treatment with Immune Checkpoint Inhibitors

Vasiliki Venetsanaki, Anastasios Boutis, Alexandra Chrisoulidou et al. · Current Oncology · 2019 · 34 citations · Full text

Medicine, Endocrinology, Oncology +16

Management of a Solitary Bone Metastasis to the Tibia from Colorectal Cancer

Anastasia Chalkidou, Anastasios Boutis, Panagiotis Padelis · Case Reports in Gastroenterology · 2009 · 16 citations · Full text

Medicine, Oncology, Surgery +17